Cloning and functional study of a novel human metallothionein-I isoform induced by paraquat

Biochemical and Biophysical Research Communications

Volumn 304, Issue 2, 2003, Pages 236-240

  Choi, Cheol Hee ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

Anthracyclines; Dichlorofluorescin; Isoform; Metallothionein; Paraquat; Reactive oxygen species; Transfection

Indexed keywords

COMPLEMENTARY DNA; DOXORUBICIN; ISOPROTEIN; METALLOTHIONEIN; PARAQUAT; PIRARUBICIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; OXIDATION; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE HOMOLOGY;

VECTORS;

EID: 0037414448     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00557-6     Document Type: Article

References (29)

1. Kojima Y., Berger C., Vallee B.L., Kagi J.H. Amino-acid sequence of equine renal metallothionein-1B. Proc. Natl. Acad. Sci. USA. 73:1976;3413-3417.
2. Webb M. Metallothionein in regeneration, reproduction and development. Experientia Suppl. 34:1979;313-320.
3. Thornalley P.J., Vasak M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta. 827:1985;36-44.
4. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med. 14:1993;325-337.
5. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. USA. 89:1992;6333-6337.
6. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J., Zambrowicz B.P., Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33:1994;7250-7259.
7. Ghoshal K., Jacob S.T. Regulation of metallothionein gene expression. Prog. Nucleic Acid Res. Mol. Biol. 66:2001;357-384.
8. Choi C.H., Kim H.S., Kweon O.S., Lee T.B., You H.J., Rha H.S., Jeong J.H., Lim D.Y., Min Y.D., Kim M.S., Chung M.H. Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines. Mol. Cells. 10:2000;38-46.
9. Pieters R., Huismans D.R., Leyva A., Veerman A.J. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Lett. 41:1988;323-332.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Lambert E., Kille P., Swaminathan R. Cloning and sequencing a novel metallothionein I isoform expressed in human reticulocytes. FEBS Lett. 389:1996;210-212.
12. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA. 82:1985;6133-6137.
13. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
14. ′ -dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress Chem. Res. Toxicol. 5:1992;227-231.
15. Shiraishi M., Utsumi K., Morimoto S., Joja I., Iida S., Takeda Y., Aono K. Inhibition of nitroblue tetrazolium reduction by metallothionein. Physiol. Chem. Phys. 14:1982;533-537.
16. Thomas J.P., Bachowski G.J., Girotti A.W. Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothioneins. Biochim. Biophys. Acta. 884:1986;448-461.
17. Sarvazyan N. Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes. Am. J. Physiol. 271:1996;H2079-H2085.
18. R.D. Olson, P.S. Mushlin, Mechanisms of anthracycline cardiotoxicity: are metabolites involved? in: D. Acosta (Ed.), Focus on Molecular, Cellular and In Vitro Toxicology, CRC Press, Boca Raton, FL, 1990, p. 51.
19. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57:1999;727-741.
20. Shadle S.E., Bammel B.P., Cusack B.J., Knighton R.A., Olson S.J., Mushlin P.S., Olson R.D. Daunorubicin cardiotoxicity: evidence for the importance of the quinone moiety in a free-radical-independent mechanism. Biochem. Pharmacol. 60:2000;1435-1444.
21. De Beer E.L., Bottone A.E., Voest E.E. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur. J. Pharmacol. 415:2001;1-11.
22. Kelley S.L., Basu A., Teicher B.A., Hacker M.P., Hamer D.H., Lazo J.S. Overexpression of metallothionein confers resistance to anticancer drugs. Science. 241:1988;1813-1815.
23. Webber M.M., Rehman S.M., James G.T. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin. Cancer Res. 48:1988;4503-4508.
24. Imura N., Naganuma A., Satoh M. Metallothionein as a resistance factor for antitumor drugs. Gan To Kagaku Ryoho. 16:1989;599-604.
25. Siegsmund M.J., Marx C., Seemann O., Schummer B., Steidler A., Toktomambetova L., Kohrmann K.U., Rassweiler J., Alken P. Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins. Urol. Res. 27:1999;157-163.
26. Kondo Y., Woo E.S., Michalska A.E., Choo K.H., Lazo J.S. Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res. 55:1995;2021-2023.
27. Kang Y.J. The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med. 222:1999;263-273.
28. Sun X., Zhou Z., Kang Y.J. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res. 61:2001;3382-3387.
29. Sun X., Kang Y.J. Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity. Exp. Biol. Med. 227:2002;652-757.